(Total Views: 256)
Posted On: 04/23/2020 11:27:05 AM
Post# of 36563
I do see at the bottom of the actual article, it says the author is Dr Eric von Hofe COO of NuGenerex Immuno-Oncology. However since that is it a public ally traded stock yet, they should add info about Generex to that.
(0)
(0)
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
